‘Positive trends’ from phase 2 amyotrophic lateral sclerosis trial
Successful results from trial of first-in-class Parkinson’s disease peptide
Researchers uncover how neurons deliver RNA where it is needed
Revvity to acquire Human Cell Design
Johnson & Johnson prostate cancer drug receives CHMP positive opinion
Breakthru Medicine emerges from stealth to develop cancer drugs
FDA Rare Pediatric Disease designation for mucopolysaccharidosis Type II treatment
CIRM approves $100m plan to accelerate genetic therapies for patients with rare diseases
Researchers develop more reliable platform to test antibody medicines
Positive topline results from acne study
Sarbecovirus vaccine trial starts
Vetter Pharma to build new manufacturing site in Germany